CordIn
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CordIn, covering 2019-06-26 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome [Phase 1, Phase 2]